DAFTAR PUSTAKA Abumossalam AM, Abdelgawad TT, Shebl AM

DAFTAR PUSTAKA
Abumossalam AM, Abdelgawad TT, Shebl AM. 2014. Malignant pleural
effusion: Relationship between thoracoscopic findings and type of
malignancy. Egyptian Journal of Chest Diseases and Tuberculosis. (in
press).
Agrawal A, Tandon R, Singh L, Chawla A. 2015. Clinico-pathological profile and
course of malignant pleural effusion in a tertiary care teaching
hospital in Western U.P. with special reference to lung cancer. Lung India;
32:326-30.
Ahmad Z, Krishnadas R, Froeschle P. 2009. Pleural effusion: Diagnosis and
management. Journal of Perioperative Practice; 19(8):242-247.
Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. 2013. Epidemiology of
lung cancer diagnosis and management of lung cancer, 3rd ed: American
college of chest physicians evidence-based clinical practice guidelines.
Chest; 143(5)(Suppl):e1S–e29S.
American Joint Committee on Cancer. 2012. Lung cancer staging 7th edition.
Anwar A, Sjahruddin E, Aniwidyaningsih W, Widyahening IS, Susanto AD.
2014. Analisis penyebab kematian pasien kanker paru. J Respir Indo; 34:
11-6.
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI.
2013. Riset Kesehatan Dasar 2013.
Bamaniya DA, Patel MZ, Kaptan KR. 2014. Pleural fluid LDH-cholesterol and
ADA levels: Useful biochemical markers in comparison to Light’s criteria
for more rapid and accurate evaluation of pleural effusion. Int J Med Sci
Public Health; 3:870-875.
Barbetakis N, Asteriou C, Papadopoulou F, Samanidis G, Paliouras D, Kleontas
A, et al. 2010. Early and late morbidity and mortality and life expectancy
following thoracoscopic talc insufflation for control of malignant pleural
effusions: A Review of 400 cases. Journal of Cardiothoracic Surgery; 5:27.
Froudarakis ME. 2008. Diagnostic work-up of pleural effusions. Respiration; 75:
4-13.
Froudarakis ME. 2012. Pleural effusion in lung cancer: More questions than
answers. Respiration; 83:367–376.
58
Fakultas Kedokteran Universitas Andalas
Görgün D, Seçik F, Midilli K, Akkaya V, Yildiz P. 2013. Diagnostic and
prognostic significance of survivin levels in malignant pleural effusion.
Respiratory Medicine; 107:1260-1265.
Haryati, Bakhriansyah M, Aisah SKN. 2013. Profil penderita kanker paru primer
di Rumah Sakit Umum Daerah Ulin Banjarmasin tahun 2006-2011. J
Respir Indo; 33(1):50-6.
Hooper C, Lee YCG, Maskell N. 2010. Investigation of a unilateral pleural
effusion in adults: British Thoracic Society pleural disease guideline 2010.
Thorax; 65(Suppl 2):ii4-ii17.
Horeweg N, van der Aalst CM, Thunnissen E, Nackaerts K, Weenink C, Groen
HJM, et al. 2013. Characteristics of lung cancers detected by computer
tomography screening in the randomized NELSON trial. Am J Respir Crit
Care Med; 187(8):848–854.
Kastelik J. 2013. Current management of pleural disorders. American Medical
Journal; 4(1):110-121.
Kellerman RD. 2014. “The respiratory system” in “Conn’s current therapy 2015”.
Philadelphia: Saunders.
Kementerian Kesehatan Republik Indonesia. 2015. Panduan nasional penanganan
kanker: Kanker paru.
Khairani R, Elisna S, Lia GP. 2012. Karakteristik efusi pleura di Rumah Sakit
Persahabatan. J Respir Indo; 32:155-60
Kushwaha R, Shashikala P, Hiremath S, Basavaraj HG. 2008. Cells in pleural
fluid and their value in differential. Journal of Cytology; 25:138-143.
Lathan CS, Okechukwu C, Drake BF, Bennett GG. 2010. Racial differences in the
perception of lung cancer. Cancer; 116:1981–6.
Lee YCG and Fysh ETH. 2011. Indwelling pleural catheter changing the
paradigm of malignant effusion management. Journal of Thoracic
Oncology; 6(4):655-657.
Light RW. 2013. Pleural diseases sixth edition. Philadelphia: Lippincott Williams
& Wilkins.
Mishra E, Davies HE, Lee YCG. 2009. Malignant pleural disease in primary lung
cancer. Eur Respir Mon; 44:318–335.
Moffett PU, Moffett BK, Laber DA. 2009. Diagnosing and managing suspected
malignant pleural effusions. J Support Oncol; 7:143–146.
59
Fakultas Kedokteran Universitas Andalas
Na MJ. 2014. Diagnostic tools of pleural effusion. Tuberc Respir Dis; 76:199210.
Pantazopoulos I, Xanthos T, Vlachos I, Kakoulas Z, Stroumpoulis K, Chalkias A,
et al. 2014. Pleural fluid glucose: A Predictor of unsuccessful pleurodesis
in a preselected cohort of patients with malignant pleural effusion. Jbuon;
19(4):1018-1023.
Perhimpunan Dokter Paru Indonesia. 2011.
penatalaksanaan kanker paru di Indonesia.
Pedoman
diagnosis
dan
Powell HA, Iyen-Omofoman B, Hubbard RB, Baldwin DR, Tata LJ. 2013. The
Association between smoking quantity and lung cancer in men and
women. Chest; 143(1):123–129.
Price SA and Wilson LM. 2005. Patofisiologi: Konsep klinis proses-proses
penyakit edisi 6. Jakarta: Penerbit Buku Kedokteran EGC.
Ridge CA, McErlean AM, Ginsberg MS. 2013. Epidemiology of lung cancer.
Seminars in Interventional Radiology; 30:93-98.
Ryu JS, Ryu HJ, Lee SN, Memon A, Lee SK, Nam HS, et al. 2014. Prognostic
impact of minimal pleural effusion in non–small-cell lung cancer. J Clin
Oncol; 32:960-967.
Satolom M, Muktiati NS, Putra NPP, Maharani A. 2012. Karakteristik vascular
endothelial growth factor, glukosa, lactate dehydrogenase, dan protein
pada efusi pleura non maligna dan efusi pleura maligna. J Respir Indo;
32:146-154.
Sjamsuhidajat R. 2010. Buku ajar ilmu bedah Sjamsuhidajat-de Jong Edisi 3.
Jakarta: Penerbit Buku Kedokteran EGC.
Soehadirman D, Yahya WSP, Isbaniyah F. 2014. Pleurodesis pada efusi pleura
ganas. J Respir Indo; 34: 218-228.
Stathopoulos GT and Kalomenidis L. 2012. Malignant pleural effusion, tumor–
host interactions unleashed. Am J Respir Crit Care Med; 186:487–492.
Supartono dan Suryanto A. 2012. Faktor-faktor yang mempengaruhi ketahanan
hidup satu tahun penderita kanker paru stadium lanjut di RSUP dr. Kariadi
Semarang. Medica Hospitalia; 1(1):25-31.
Surjanto E, Sutanto YS, Aphridasari J, Leonardo. 2014. Penyebab efusi pleura
pada pasien rawat inap di rumah sakit. J Respir Indo; 34:102-8.
60
Fakultas Kedokteran Universitas Andalas
Syahruddin E. 2010. Efusi pleura ganas dan sistem TNM untuk staging kanker
paru jenis karsinoma bukan sel kecil (KPKBSK) Versi 7, UICC 2009. J
Respir Indo; 30(3):132-133.
Syahruddin E, Hudoyo A, Arief N. 2009. Efusi pleura ganas pada kanker paru. J
Respir Indonesia; 29(4).
Syahruddin E, Pratama AD, Arief N. 2010. A Retrospective Study: Clinical and
diagnostic characteristics in advanced stage of lung cancer patients with
pleural effussion in Persahabatan Hospital 2004 – 2007. J Respir Indo;
30(3):146-151.
Tokgöz F, Göksenoglu N, Bodur Y, Aksoy E, Aktas O, Sevim T. 2014.
Retrospective analysis of 240 cases with pleural effusion. Eurasian J
Pulmonol; 16:78-83.
Underwood JM, Townsend JS, Tai E, Davis SP, Stewart SL, White A, et al. 2012.
Racial and regional disparities in lung cancer incidence. Cancer; 118:
1910-8.
Walser T, Xiaoyan C, Yanagawa J, Lee JM, Heinrich E, Lee G, et al. 2008.
Smoking and lung cancer. Proc Am Thorac Soc; 5:811-815.
Weinberger SE, Cockrill BA, Mandel J. 2014. Principles of pulmonary medicine,
sixth edition. Philadelphia: Saunders.
World Health Organization. 2015. Cancer Fact Sheet.
Wu SG, Yu CJ, Tsai MF, Liao WY, Yang CH, Jan IS, et al. 2013. Survival of
lung adenocarcinoma patients with malignant pleural effusion. Eur Respir
J; 41:1409–1418.
Yu H. 2011. Management of pleural effusion, empyema, and lung abscess. Semin
Intervent Radiol; 28:75–86.
Zamboni MM, da Silva CT, Baretta R, Cunha ET, Cardoso GP. 2015. Important
prognostic factors for survival in patients with malignant pleural effusion.
BMC Pulmonary Medicine; 15:29.
Zarogoulidis K, Zarogoulidis P, Darwiche K, Tsakiridis K, Machairiotis N,
Kougioumtzi I, et al. 2013. Malignant pleural effusion and algorithm
management. J Thorac Dis; 5(S4):S413-S419.
Ziaian B, Saberi A, Ghayyoumi MA, Safaei A, Ghaderi A, Mojtahedi Z. 2014.
Association of high LDH and low glucose levels in pleural space with
HER2 expression in non-small cell lung cancer. Asian Pac J Cancer Prev;
15(4):1617-1620.
61
Fakultas Kedokteran Universitas Andalas